Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

LABP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Landos Biopharma Insider Trading History Chart

Landos Biopharma Share Price & Price History

^$21.82

▲ +0.07 (0.32%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Landos Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/23/2022	Rtw Investments, Lp	Major Shareholder	Sell	30,000	$6.90	$207,000.00	397,572
12/20/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	3,319	$47.50	$157,652.50
12/17/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	3,600	$48.40	$174,240.00
12/15/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	4,300	$50.20	$215,860.00
12/13/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	4,000	$53.70	$214,800.00
12/10/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	4,000	$57.70	$230,800.00
12/8/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	2,553	$66.50	$169,774.50
12/6/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	3,600	$61.70	$222,120.00
12/3/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	3,600	$61.50	$221,400.00
12/1/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	3,223	$70.10	$225,932.30
11/29/2021	Josep Bassaganya-Riera	Major Shareholder	Sell	1,543	$75.80	$116,959.40

Your Money is Not Safe

From American Alternative | Ad

CLICK HERE TO GET YOUR GUIDE NOW

SEC Filings (Institutional Ownership Changes) for Landos Biopharma (NASDAQ:LABP)

49.06% of Landos Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Landos Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2024	Deltec Asset Management LLC	50,000	$1.07M	0.2%	N/A	1.603%
8/24/2023	Perceptive Advisors LLC	1,486,991	$6.26M	0.2%	-90.0%	47.660%
2/13/2023	Renaissance Technologies LLC	125,401	$63K	0.0%	-51.5%	0.311%
2/10/2023	HRT Financial LP	52,564	$26K	0.0%	N/A	0.131%
11/15/2022	Vanguard Group Inc.	166,608	$0.11M	0.0%	+30.6%	0.414%
11/14/2022	RTW Investments LP	3,975,722	$2.58M	0.1%	-7.0%	9.876%
11/14/2022	Renaissance Technologies LLC	258,701	$0.17M	0.0%	-33.5%	0.643%
11/1/2022	OUP Management Co. LLC	1,237,667	$0.80M	1.3%	-23.3%	3.074%
10/31/2022	Green Square Capital Advisors LLC	84,500	$55K	0.0%	N/A	0.210%
8/18/2022	Goldman Sachs Group Inc.	42,800	$31K	0.0%	+119.1%	0.106%
8/13/2022	Renaissance Technologies LLC	388,732	$0.28M	0.0%	+14.2%	0.966%
7/19/2022	OUP Management Co. LLC	1,612,764	$1.17M	1.6%	-11.7%	4.006%
6/7/2022	Bank of America Corp DE	56,321	$83K	0.0%	+80.4%	0.140%
5/13/2022	Renaissance Technologies LLC	340,500	$0.50M	0.0%	+99.0%	0.846%
5/13/2022	Vanguard Group Inc.	159,001	$0.23M	0.0%	-47.8%	0.395%
5/12/2022	BlackRock Inc.	520,308	$0.77M	0.0%	+10.6%	1.293%
3/3/2022	Walleye Capital LLC	105,208	$0.51M	0.0%	N/A	0.262%
2/10/2022	Acadian Asset Management LLC	8,274	$39K	0.0%	N/A	0.021%
2/3/2022	OUP Management Co. LLC	1,827,478	$8.77M	4.0%	N/A	4.555%
11/12/2021	Geode Capital Management LLC	112,933	$1.65M	0.0%	-11.4%	0.282%
11/12/2021	Botty Investors LLC	128,750	$1.88M	0.6%	+4.9%	0.321%
11/9/2021	BlackRock Inc.	233,616	$3.41M	0.0%	-20.6%	0.582%
11/4/2021	Deutsche Bank AG	2,693	$39K	0.0%	-30.0%	0.007%
11/2/2021	Cambridge Investment Research Advisors Inc.	18,831	$0.28M	0.0%	N/A	0.047%
11/2/2021	New York State Common Retirement Fund	2,756	$40K	0.0%	-62.5%	0.007%
11/2/2021	Allworth Financial LP	5,286	$77K	0.0%	N/A	0.013%
10/22/2021	Strs Ohio	11,400	$0.17M	0.0%	+660.0%	0.028%
8/17/2021	Logos Global Management LP	899,106	$10.39M	0.9%	+22.5%	2.241%
8/16/2021	Tudor Investment Corp Et Al	17,793	$0.21M	0.0%	-71.3%	0.044%
8/16/2021	State Street Corp	92,367	$1.07M	0.0%	+88.1%	0.230%
8/13/2021	Botty Investors LLC	122,781	$1.42M	0.5%	+26.0%	0.306%
8/13/2021	Geode Capital Management LLC	127,518	$1.47M	0.0%	+15.3%	0.318%
8/13/2021	Vanguard Group Inc.	305,185	$3.52M	0.0%	+61.9%	0.761%
8/11/2021	Bank of New York Mellon Corp	14,029	$0.16M	0.0%	+37.8%	0.035%
8/11/2021	BlackRock Inc.	294,043	$3.40M	0.0%	+14.7%	0.733%
5/27/2021	Davidson Kempner Capital Management LP	50,000	$0.48M	0.0%	N/A	0.125%
5/19/2021	Logos Global Management LP	734,000	$7.07M	0.7%	N/A	1.830%
5/19/2021	Squarepoint Ops LLC	15,361	$0.15M	0.0%	N/A	0.038%
5/18/2021	Zimmer Partners LP	90,100	$0.87M	0.0%	N/A	0.225%
5/18/2021	Tudor Investment Corp Et Al	61,899	$0.60M	0.0%	N/A	0.154%
5/18/2021	Orbimed Advisors LLC	681,000	$6.56M	0.1%	N/A	1.697%
5/18/2021	Davidson Kempner Capital Management LP	50,000	$0.48M	0.0%	N/A	0.125%
5/18/2021	Old Well Partners LLC	18,316	$0.18M	0.1%	N/A	0.046%
5/18/2021	California State Teachers Retirement System	9,518	$92K	0.0%	N/A	0.024%
5/17/2021	Deerfield Management Company L.P. Series C	450,000	$4.33M	0.1%	N/A	1.122%
5/17/2021	Perceptive Advisors LLC	17,960,839	$159.69M	2.0%	N/A	44.770%
5/17/2021	Woodline Partners LP	213,335	$2.05M	0.0%	N/A	0.532%
5/17/2021	Caas Capital Management LP	40,000	$0.39M	0.0%	N/A	0.100%
5/17/2021	Nuveen Asset Management LLC	10,219	$98K	0.0%	N/A	0.025%
5/17/2021	Sphera Funds Management LTD.	70,000	$0.67M	0.1%	N/A	0.174%
5/14/2021	Laurion Capital Management LP	10,000	$96K	0.0%	N/A	0.025%
5/14/2021	RTW Investments LP	4,275,722	$38.33M	0.6%	N/A	10.658%
5/14/2021	Monashee Investment Management LLC	91,309	$0.88M	0.1%	N/A	0.228%
5/13/2021	Bank of New York Mellon Corp	10,182	$98K	0.0%	N/A	0.025%
5/13/2021	Botty Investors LLC	97,477	$0.94M	0.3%	N/A	0.243%
5/12/2021	Northern Trust Corp	74,359	$0.72M	0.0%	N/A	0.185%
5/12/2021	Geode Capital Management LLC	110,559	$1.06M	0.0%	N/A	0.276%
5/12/2021	Ensign Peak Advisors Inc	125,000	$1.20M	0.0%	N/A	0.312%
5/12/2021	JPMorgan Chase & Co.	375,021	$3.61M	0.0%	N/A	0.935%
5/11/2021	Teacher Retirement System of Texas	10,000	$96K	0.0%	N/A	0.025%
5/11/2021	New York State Common Retirement Fund	7,300	$70K	0.0%	N/A	0.018%
5/7/2021	BlackRock Inc.	256,290	$2.47M	0.0%	N/A	0.639%
5/7/2021	American International Group Inc.	3,677	$35K	0.0%	N/A	0.009%

Data available starting January 2016

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate is NX-13, an oral gut-selective Nucleotide Oligomerization Domain (NLRX1), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines that completed Phase Ib clinical trial to treat ulcerative colitis (UC), as well as induce anti-inflammatory effects in CD4+ T cells and other cells in the gastrointestinal tract. The company's preclinical candidates in development include LABP-73, an oral and small molecule NLRX1 pathway agonist in development for the treatment of asthma and chronic obstructive pulmonary disease; LABP-66 is an oral and small molecule NLRX1 pathway agonist for the treatment of multiple sclerosis and Alzheimer's disease; and LABP-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and RA. The company has a strategic research collaboration with KU Leuven and University Hospitals Leuven to investigate the effects of NX-13 on epithelial cells with the inflammatory bowel disease. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia.

Today's Range

Now: $21.82

$21.60

$21.82

50 Day Range

MA: $12.39

$5.21

$21.82

52 Week Range

Now: $21.82

$2.50

$21.87

Volume

14,682 shs

Average Volume

22,526 shs

Market Capitalization

$68.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.14

Who are the company insiders with the largest holdings of Landos Biopharma?: Landos Biopharma's top insider investors include:
Rtw Investments, Lp (Major Shareholder)
Learn More about top insider investors at Landos Biopharma.
Who are the major institutional investors of Landos Biopharma?: Landos Biopharma's top institutional investors include:
Deltec Asset Management LLC — 1.60%
Learn More about top institutional investors of Landos Biopharma stock.
Which institutional investors are buying Landos Biopharma stock?: Within the previous quarter, LABP stock was bought by institutional investors including:
Deltec Asset Management LLC